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Background: Immune recovery is an important determinant of
outcome after allogeneic hematopoietic stem cell transplantation (al-
loHSCT).While T cell depleted (TCD) alloHSCT has a low risk of
graft-versus-host disease (GVHD), older adult recipients of a TCD
alloHSCTexperience deficiencies in their B andTcell reconstitution
that can persist for more than one year. We have previously shown
that the rate of recovery ofCD41Tcells followingTCD-alloHSCT
correlates with the risk of developing opportunistic infections. How-
ever, it is not known if there are any earlier immunologic predictors of
clinical outcome in the fully TCD setting.
Methods:We conducted a retrospective study of 85 consecutive
patients (median age 36, range 4–63) who received an TCD-al-
loHSCT for primary AML between January 1997 and December
2005 at MSKCC. Patients were in hematologic CR and were alive
with stable engraftment at 30 days. Immune recovery data for the
first 90 days, including absolute lymphocyte count and lymphocyte
subsets, was grouped by tertile of cohort. We also evaluated other
factors including sex of patient/donor, stage, cytogenetic risk, stem
cell source, preparative regimen, and HLA match. Kaplan-Meier
method was used to estimate overall survival (OS) and disease
free survival (DFS). The log rank test for discrete covariates and
the Cox regression model for continuous covariates were used to
determine the significance of differences in survival between
groups.
Results: Absolute lymphocyte count at day 30 (ALC30) was sig-
nificantly associated with improved OS (p 5 0.022) and a trend to-
wards improved DFS (p 5 0.082). The tertile cohorts for ALC30
were\ 0.3, 0.3–0.628, .0.628  103/mcl. Lymphocyte subsets, in-
cluding CD41, CD81, and NK cells, were not associated with OS
or DFS in the first 90 days, although the analysis may have been in-
sufficiently powered because data were not available for all patients.
Degree of HLAmatch was the only other factor predictive of OS and
DFS (p 5 0.018, 0.01).
Conclusions:WeconcludeALC30 is an early predictor ofOS and
DFS in the fully TCD setting. These results are in agreement with
earlier work demonstrating ALC30 predicts OS and relapse rate in
conventional and partially TCD transplants. Because our group is
currently investigating agents like IL-7 andKGF to improve immune
reconstitution followingTCD-alloHSCT, these results offer power-
ful guidance forwhich patientsmay benefitmost from these interven-
tions.396
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Patients receiving autologous hematopoietic stem cell transplan-
tation (HSCT) or bone marrow transplantation (BMT) as therapy
for various malignancies or autoimmune diseases have an increased
risk for infectious complications post-transplant, especially in the
lung.We have used syngeneic BMT inmice and the murine gamma-
herpesvirus, MHV-68, to study the efficacy of adaptive immune re-
sponses post-HSCT. Using this model, we have shown that mice 5
weeks post-transplant have fully reconstituted their hematopoeitic
lineages in both the lung and periphery. However, the BMT mice
have a reduced ability to clear lytic virus from the lung, despite in-
creased expression of interferon gamma, interleukin-2, and TNF-al-
pha in the lungs of BMT mice. Recruitment of immune cells to the
lungs after MHV-68 infection is similar in BMT mice and untrans-
planted controls, suggesting functional defects.While bone-marrow
derived dendritic cells from transplanted mice are able to stimulate
allogeneic T cell proliferation in mixed leukocyte reactions
(MLRs), CD41 T cells from BMTmice show reduced proliferative
responses in MLRs. These results suggest defects in CD41 T cell
responses post-BMT may contribute to enhanced susceptibility to
viral infections. Studies to elucidate the mechanisms of these defects
are currently underway.TRANSPLANT NURSING-ADMINISTRATION397
EXPLORING CULTURAL DIVERSITY
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Goals: To promote cultural awareness and improve our under-
standing of the cultural diversityof our teammembers andour patients.
Background: At our large teaching hospital in Northern Califor-
nia, there are approximately 100 team members providing care for
transplant recipients and families. On our interdisciplinary team
we have 15 different cultures represented, which is also a reflection
of our patient population. We have team members from Ethiopia,
Kenya, The Phillipines, India, Fiji, Mexico, Cuba, Canada, Albania,
Iran, Russia, Vietnam, China, Belgium, and Portugal.
Project: Once a month a staff member is chosen for a Cultural
Question and Answer (Q&A) session and potluck. The staff member
presents information on his/her culture including topics such as his-
tory, government, education, cuisine, and the health care system. For
the potluck, everybody brings a dish representative of the culture. In
addition to asking about the country and culture, the moderator also
asks about the experiences of the staff member as an immigrant to the
United States such as: Why did you immigrate? How long have you
been in this country?What was the hardest custom to adapt or cope
with since you arrived in the United States?
Results: At our first potluck, over 16members of the interdisciplin-
ary teamattended tohear about the culture ofEthopia.The enthusiasm
was evident as virtually all who attended actively participated. At the
end of the Q&A, the staff discussed how to apply what we learned to
our daily practice in caring for patients of that particular cultural back-
ground. A second benefit is that it helps to build a more cohesive team
based on an improved cultural understanding of each other. The Cul-
tural Q&A is proving to be a fun and easy way to promote cultural
awareness and improve our understanding of different cultures.398
HOWUABHOSPITAL’S BMT UNIT USED COLLABORATIVE PARTNERSHIPS
TO ANSWER THE CALL OF AN INCREASED NEED FOR HOUSE ICU BEDS
WHILE ADDRESSING ISSUES OF A FLUCTUATING BMT SPECIALTY
CENSUS
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University of Alabama at Birmingham Hospital’s Bone Marrow
Transplantation and Cell Therapy Unit (BMT) is a unique unit that
takes pride in having certified nurses who excel in their field. Putting
patients and their safety first is the key element in our unit’s culture.
Through interdisciplinary collaboration, we restructured our unit to
address the needs of the BMT service and the issues following BMT
census fluctuation. This census fluctuation resulted in an increase in
non BMT patients including post surgical, orthopedic, hospitalist,
and many other varying patient types increasing infection risks to
our vulnerable patient populations and decreasing staff satisfaction.
Unit leaders recognized the need for the organization to increase the
number of ICU beds and the unit’s need to build a partnership with
another specialty. We collectively made a decision to become the des-
ignated overflowunit forMICUpatients during drops inBMTcensus.
While the partnership with MICU could not be monogamous, open-
ing the doors toMICU alsomeant opening to all ICU services in need
and therefore officially claiming BMT as a needed addition to the in-
tensive care units at UAB Hospital. Education of the staff remains an
ever changing process improvement on our unit. Culture initiatives to
keep morale high during change continue to be a focus point for unit
leaders. The partnership has proven to be both challenging and re-
warding. The benefits and success stories of the patients we have
helped far outweigh the challenges and grief. Our focus supports our
unit motto. Always About Them, Never About Us.399
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